Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
PAML and BloodworksNW Enter Into a Strategic Collaboration
...
Foundation Medicine Enters Into Collaborative Agreement with NCI
...
Cyrex Laboratories Introduces Food-Related Autoimmune Test Panel
...
Despite Big Write-offs, Quest & LabCorp Report Strong First Quarters
...
Quest Launches New Tests for Blood-Based Cancers
...
Report Indicates Patients Seek Transparency, Choices and Convenience in Health Care Billing
By Kelly A. Briganti, Editorial Director, G2 Intelligence A new report released this month by PricewaterhouseCoopers (PwC) describes the U.S. health care industry's billing and payment system as "a horse-and-buggy in a world contemplating driverless cars." The...
Many Not Getting Colorectal, Cervical Cancer Screenings
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Many adults are not getting recommended, routine screenings for cervical and colorectal cancer, according to the U.S. Centers for Disease Control and Prevention (CDC). Screening rates for...
Exosome Prostate Cancer Test Does Well in Clinical Validation Study
By Ron Shinkman, Editor, Laboratory Industry Report Massachusetts-based Exosome Diagnostics has released data from a clinical validation study suggesting its liquid biopsy test for prostate cancer patients could more accurately predict the presence of the disease...
Whistleblowers Can Offer Statistical Sampling to Support Fraud Claims
...
CAP and ADASP Recommend Secondary Review of Anatomic Pathology Cases
...